Innovation1 Biotech Stock Current Valuation
| IVBT Stock | USD 0 0.00 0.00% |
Valuation analysis of Innovation1 Biotech helps investors to measure Innovation1 Biotech's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Innovation1 Biotech's price fluctuation is very steady at this time. Calculation of the real value of Innovation1 Biotech is based on 3 months time horizon. Increasing Innovation1 Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Innovation1 otc stock is determined by what a typical buyer is willing to pay for full or partial control of Innovation1 Biotech. Since Innovation1 Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Innovation1 OTC Stock. However, Innovation1 Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 8.4E-4 | Hype 0.001 | Naive 0.001 |
The intrinsic value of Innovation1 Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Innovation1 Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Innovation1 Biotech helps investors to forecast how Innovation1 otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Innovation1 Biotech more accurately as focusing exclusively on Innovation1 Biotech's fundamentals will not take into account other important factors: Innovation1 Biotech OTC Stock Current Valuation Analysis
Innovation1 Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Innovation1 Biotech Current Valuation | 1.83 M |
Most of Innovation1 Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innovation1 Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Innovation1 Biotech has a Current Valuation of 1.83 M. This is 99.99% lower than that of the Healthcare sector and 99.96% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Innovation1 Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Innovation1 Biotech's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Innovation1 Biotech could also be used in its relative valuation, which is a method of valuing Innovation1 Biotech by comparing valuation metrics of similar companies.Innovation1 Biotech is currently under evaluation in current valuation category among its peers.
Innovation1 Fundamentals
| Return On Equity | -1.79 | |||
| Return On Asset | -0.0781 | |||
| Current Valuation | 1.83 M | |||
| Shares Outstanding | 20.02 M | |||
| Shares Owned By Insiders | 74.66 % | |||
| Price To Earning | 0.01 X | |||
| Price To Book | 0.05 X | |||
| Gross Profit | (17 K) | |||
| EBITDA | (38.33 M) | |||
| Net Income | (40.88 M) | |||
| Cash And Equivalents | 636.16 K | |||
| Cash Per Share | 0.03 X | |||
| Total Debt | 554.4 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | 0.10 X | |||
| Cash Flow From Operations | (3.13 M) | |||
| Earnings Per Share | 5.54 X | |||
| Beta | 5.08 | |||
| Market Capitalization | 4.5 M | |||
| Total Asset | 43.96 M | |||
| Z Score | 4.8 | |||
| Net Asset | 43.96 M |
About Innovation1 Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Innovation1 Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Innovation1 Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Innovation1 Biotech based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.